Table 3.
Summary of the estimated postoperative complication rates for patients with RA receiving THA
| Percentage of complications (CI) | |||||
|---|---|---|---|---|---|
| 1980–1989 | 1990–1999 | 2000–2009 | 2010–2019 | 1980–2019 | |
| VTE | 2 (0–6.1)a | No studies | 1.9 (0–7.9)a | 0.3 (0–0.6) | 0.4 (0–1.2) |
| Dislocation | No papersb | 1.1 (0–4.3)a | 0.4 (0.1–0.8) | 1.5 (0.5–3) | 0.8 (0.2–1.7) |
| Periprosthetic fracture | No papersb | 0.6 (0.2–1.1)a | 1.0 (0–3.9) | 0.4 (0.1–0.8) | 0.3 (0.1–0.6) |
| Aseptic loosening | 16.2 (5.8–30.1)a | 2.8 (1.5–4.5) | 3.8 (1.4–7.2) | 3.8 (0–11.9) | 4.0 (2.2–6.4) |
| Infection | 2.7 (0.3–6.7)a | 2.3 (1.1–3.9) | 2.3 (0–8.7) | 2.6 (0.8–5.2) | 2.6 (1.4–4.2) |
| Revision | 12.9 (0–42.3)a | 8.1 (4.4–12.8) | 8.5 (4.7–13.2)a | 6.2 (2.3–11.5) | 8.8 (6.1–11.9) |
| 90-day mortality | No papersb | 0a | 0.7 (0.3–1.4)a | 0.6 (0.2–1.1) | 0.6 (0.2–1.1) |
| Complication rate | 25.1 (0–70.8)a | 9.9 (6.2–14.4) | 12.7 (7.3–19.2) | 5.3 (2.5–8.9) | 12.8 (8.4–17.9) |
aInsufficient number of studies to meet the cut-off criteria of three studies, and hence these results should be used and interpreted with caution as they may not be representative of the broader population
bCategory could not be calculated as a result of limited studies